Evommune EVMN Number of Operating Segments

Segments

HT Natural Segments2—

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Market cap$869.12M+42.8%

Enterprise value$870.05M—

P/S130.4×—

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—